Shares in Mediwatch fell after the medical diagnostic equipment maker said talks with an unidentified potential buyer had ended.

The company, whose equipment is used to test and monitor bladder and prostate diseases, said the suitor - thought to be in the medical and healthcare sector - ended talks because of deteriorating market conditions.